degarelix accord
accord healthcare s.l.u. - degarelix acetate - prostatične neoplazme - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
intrinsa
warner chilcott uk ltd. - testosteron - spolne disfunkcije, psihološke - spolni hormoni in zdravila genitalni sistem, - intrinsa je indiciran za zdravljenje hipoaktivne spolne želje motnjo (hsdd) v dvostransko oophorectomised in hysterectomised (kirurško inducirane menopavze) ženske prejemajo sočasne estrogensko zdravljenje.
livensa
warner chilcott deutschland gmbh - testosteron - spolne disfunkcije, psihološke - spolni hormoni in zdravila genitalni sistem, - livensa je indicirano za zdravljenje hipoaktivne spolne želje motnjo (hsdd) v dvostransko oophorectomised in hysterectomised (kirurško inducirane menopavze) ženske prejemajo sočasne estrogensko zdravljenje.
firmagon
ferring pharmaceuticals a/s - degareliks - prostatične neoplazme - endokrini terapija - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
camcevi
accord healthcare s.l.u. - leuprorelin mesilate - prostatične neoplazme - endokrini terapija - camcevi is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy.
testim 50 mg transdermalni gel
ferring gmbh - testosteron - transdermalni gel - testosteron 50 mg / 5 g - testosteron
testarzon 23 mg/pritisk transdermalni gel
testosteron - transdermalni gel - testosteron 23 mg / 1 odmerek - testosteron
testarzon 23 mg/pritisk transdermalni gel
testosteron - transdermalni gel - testosteron 23 mg / 1 odmerek - testosteron
nebido 1000 mg/4 ml raztopina za injiciranje
bayer d.o.o. - testosteron - raztopina za injiciranje - testosteron 157,9 mg / 1 ml - testosteron
nebido 1000 mg/4 ml raztopina za injiciranje
bayer d.o.o. - testosteron - raztopina za injiciranje - testosteron 157,9 mg / 1 ml - testosteron